Phyton Biotech, a subsidiary of DFB Pharmaceuticals, established in 1990, specializes in Upstream/Downstream Process Development and Scale-upPilot Fermentation Facility with tanks ranging from 16 liters to 7500 liters; Capabilities in Small Molecule Purification and Semi-Synthesis involving complex chemistryCommercial Production and Global DistributionCommercial Fermentation Facility equipped with 1 tank of 45,000 liters and 2 tanks of 75,000 liters for metric tonne output capacity. Using its Plant Cell Fermentation (PCF) technology, Phyton Biotech is the largest producer of high-quality paclitaxel and docetaxel globally. It provides integrated contract product and process development as well as commercial manufacturing services for the pharmaceutical, cosmetic, agricultural and food ingredient industries. The company's facilities in Germany and Canada have been inspected and are in compliance with international GMP requirements.
Products & Services
Docetaxel
Country
Phyton Biotech
Country
City
Address
Docetaxel Anhydrous
Country
Phyton Biotech
Country
City
Address
Paclitaxel
Country
Phyton Biotech
Country
City
Address
Country
Phyton Biotech GmbH Una-Synth GmbH
Country
City
Paclitaxel Fermentation R1-CEP 2011-324-Reo 01
Phyton Biotech LLC
Country
City
Address
Sites
Phyton Biotech LLC
Country
City
Address
Phyton Biotech GmbH Una-Synth GmbH
Country
City
Phyton Biotech
Country
City
Address
Country
City
Address
Country
City
Address